1. Home
  2. CMP vs KALV Comparison

CMP vs KALV Comparison

Compare CMP & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Minerals Intl Inc

CMP

Compass Minerals Intl Inc

HOLD

Current Price

$29.25

Market Cap

1.0B

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMP
KALV
Founded
1993
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2003
2014

Fundamental Metrics

Financial Performance
Metric
CMP
KALV
Price
$29.25
$26.72
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$21.50
$32.60
AVG Volume (30 Days)
500.3K
4.4M
Earning Date
05-06-2026
07-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.73
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
N/A
$185.42
Revenue Next Year
$1.29
$59.23
P/E Ratio
$38.16
N/A
Revenue Growth
N/A
495.66
52 Week Low
$16.40
$9.83
52 Week High
$30.04
$26.85

Technical Indicators

Market Signals
Indicator
CMP
KALV
Relative Strength Index (RSI) 66.28 75.27
Support Level $20.08 $14.66
Resistance Level N/A N/A
Average True Range (ATR) 1.64 0.44
MACD 0.24 0.35
Stochastic Oscillator 87.25 98.47

Price Performance

Historical Comparison
CMP
KALV

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: